Jacqueline Claire Lupo
Vorstandsvorsitzender bei LOPHOS HOLDINGS INC.
Vermögen: 440 000 $ am 31.05.2024
Aktive Positionen von Jacqueline Claire Lupo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LOPHOS HOLDINGS INC. | Direktor/Vorstandsmitglied | 23.12.2021 | - |
| Vorstandsvorsitzender | 23.12.2021 | - | |
Lophos Pharmaceuticals Corp.
 Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Direktor/Vorstandsmitglied | 01.01.2021 | - |
| Vorstandsvorsitzender | 01.09.2021 | - | |
| Gründer | 01.01.2021 | - | |
| Präsident | 01.09.2021 | - | |
| Northern Green Canada, Inc. | Corporate Officer/Principal | - | - |
Karriereverlauf von Jacqueline Claire Lupo
Ehemalige bekannte Positionen von Jacqueline Claire Lupo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Canalytica Corp. | Gründer | - | - |
Statistik
International
| Kanada | 5 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sektoral
| Process Industries | 2 |
| Health Technology | 2 |
| Consumer Non-Durables | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LOPHOS HOLDINGS INC. | Process Industries |
| Private Unternehmen | 3 |
|---|---|
Lophos Pharmaceuticals Corp.
Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Health Technology |
| Northern Green Canada, Inc. | Consumer Non-Durables |
| Canalytica Corp. |
- Börse
- Insiders
- Jacqueline Claire Lupo
- Erfahrung
